Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
about
Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cellsAbnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1Interactions between Aβ oligomers and presynaptic cholinergic signaling: age-dependent effects on attentional capacitiesPositron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's diseaseEarly accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brainEarly fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model.In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function.Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's diseaseA new role for laminins as modulators of protein toxicity in Caenorhabditis elegans.Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.Microbiosensor for Alzheimer's disease diagnostics: detection of amyloid beta biomarkers.Synaptic activity and Alzheimer's disease: a critical update.In vivo hippocampal microdialysis reveals impairment of NMDA receptor-cGMP signaling in APP(SW) and APP(SW)/PS1(L166P) Alzheimer's transgenic miceMitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's DiseaseRNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer's disease.Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connectionsAxonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system.The potential role of rho GTPases in Alzheimer's disease pathogenesis.Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation.Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus.Conformational targeting of intracellular Aβ oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum.Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system.Aβ internalization by neurons and glia.Effects of curcumin on synapses in APPswe/PS1dE9 mice.MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update.
P2860
Q27022080-56599537-540C-4F27-B7A3-63DED60C42D2Q27314013-CCB18A27-16F9-42E6-87F2-603B86F68C07Q27331407-EB2DD089-DBE4-4C21-8F22-3348F9FB90A9Q30497749-B40CC8C0-2E9C-45EB-BD80-10D11D236D0CQ30534746-5984AC81-F5E6-4448-8E9A-88053699429FQ30542245-959FC1BA-5357-4B2B-8D74-7C58EEA447F2Q34609073-2E2188B0-8CF2-4B72-874E-1F8E4CFBB695Q35302742-9A919B10-DCBF-4859-A03B-E6BB1CCE11BEQ35532902-1AE1CA05-0DCD-43EB-8BC1-403F923E1C74Q35670325-700ED420-D6D3-4853-9E42-B5664C2527EDQ35974488-006C10CF-D0F1-4D32-B073-746400BD3071Q36044229-55B7C1F1-AC24-43A4-9139-D7B27A0B7E93Q36245276-90212AF0-72B4-4080-AD64-FF6C2F9ABEC0Q36428310-52661A76-F561-4864-B718-05995FEC7D7EQ36441971-FD76F95E-0DA9-4CAA-8F51-5C7467F0F37FQ37315215-0CA26826-1AB6-428F-B385-01D82F225AC4Q37315981-3C4B3786-4CD1-481F-B5B5-B413B436F184Q38014513-9A03D68F-4623-477E-85A0-71C4C143C351Q38020618-BFFEFFAA-902D-4D8C-A880-3C7FD103EA64Q38180966-E4FA6F5A-74FD-493E-933D-C09F26E922EAQ38684346-AB779282-9985-47DA-95B5-D2813A5B0E79Q40086136-C3F60B55-E38F-427A-9B92-3E5EADB3B694Q40470312-8E909D67-5DE7-40C1-A069-F871442946F1Q42386276-8C2CDFA9-2E44-496F-8016-C001D696F059Q42620803-E468A072-929B-4481-A348-900BA9105C87Q48849905-C31DF26E-3EA9-4F56-91BF-BEF27B2D5854Q51764195-1CCBD734-79B5-4E05-A671-55853FAF5BE9
P2860
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@ast
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@en
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@nl
type
label
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@ast
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@en
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@nl
prefLabel
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@ast
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@en
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@nl
P2860
P356
P1476
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
@en
P2093
Davide Tampellini
P2860
P356
10.3389/FNAGI.2010.00013
P577
2010-05-21T00:00:00Z